Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-009852
Filing Date
2017-01-13
Accepted
2017-01-13 16:07:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A (AMENDMENT NO.3) d278005ds3a.htm S-3/A 63177
2 EX-23.1 d278005dex231.htm EX-23.1 1549
  Complete submission text file 0001193125-17-009852.txt   66014
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-3/A | Act: 33 | File No.: 333-214315 | Film No.: 17527858
SIC: 2834 Pharmaceutical Preparations